Advisor Group Holdings, Inc. Athira Pharma, Inc. Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 81,300 shares of ATHA stock, worth $28,455. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,300

Previous 82,350 1.28%

Holding current value

$28,455

Previous $37,000 27.03%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$0.42 - $0.8 $441 - $840	-1,050 Reduced 1.28%	81,300 $47,000
Q3 2024 Nov 13, 2024	BUY	$0.42 - $3.43 $21,966 - $179,389	52,300 Added 174.04%	82,350 $37,000
Q2 2024 Aug 13, 2024	SELL	$1.92 - $2.71 $256,394 - $361,890	-133,539 Reduced 81.63%	30,050 $79,000
Q1 2024 May 10, 2024	SELL	$2.24 - $4.15 $14,371 - $26,626	-6,416 Reduced 3.77%	163,589 $448,000
Q4 2023 Feb 12, 2024	BUY	$1.39 - $2.46 $38,831 - $68,722	27,936 Added 19.66%	170,005 $413,000
Q3 2023 Nov 13, 2023	SELL	$1.9 - $3.16 $9,310 - $15,484	-4,900 Reduced 3.33%	142,069 $286,000
Q2 2023 Aug 10, 2023	BUY	$2.36 - $3.59 $23,128 - $35,182	9,800 Added 7.14%	146,969 $433,000
Q1 2023 May 12, 2023	SELL	$2.26 - $4.22 $21,243 - $39,668	-9,400 Reduced 6.41%	137,169 $342,000
Q4 2022 Feb 10, 2023	BUY	$2.76 - $3.71 $29,117 - $39,140	10,550 Added 7.76%	146,569 $464,000
Q3 2022 Nov 14, 2022	BUY	$2.93 - $3.96 $2,930 - $3,960	1,000 Added 0.74%	136,019 $404,000
Q2 2022 Aug 10, 2022	BUY	$2.74 - $13.43 $1,370 - $6,715	500 Added 0.37%	135,019 $412,000
Q1 2022 May 04, 2022	BUY	$8.96 - $13.51 $32,480 - $48,973	3,625 Added 2.77%	134,519 $1.82 Million
Q3 2021 Nov 05, 2021	SELL	$9.15 - $11.09 $915 - $1,109	-100 Reduced 0.08%	130,894 $1.23 Million
Q2 2021 Aug 02, 2021	BUY	$10.24 - $20.87 $1.19 Million - $2.42 Million	115,814 Added 762.94%	130,994 $1.34 Million
Q1 2021 May 13, 2021	BUY	$16.9 - $29.77 $13,519 - $23,816	800 Added 5.56%	15,180 $279,000
Q4 2020 Feb 10, 2021	BUY	$16.48 - $34.3 $235,334 - $489,803	14,280 Added 14280.0%	14,380 $493,000
Q3 2020 Nov 12, 2020	BUY	$16.02 - $18.46 $1,602 - $1,846	100 New	100 $2,000

Others Institutions Holding ATHA

# of Institutions

Shares Held

18.8M

Call Options Held

17.2K

Put Options Held

800

View Full List

About Athira Pharma, Inc.

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $13.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

More about ATHA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Athira Pharma, Inc. Transaction History